Drug intelligence / Profile preview

diclofenac diethylamine + linseed oil + menthol + methyl salicylate (Sun Pharma)

Development stage
Unknown
Lead developer
Sunlife
Modality
Small Molecules
Administration
Topical
01

Overview

Mobistarr is a topical analgesic and anti-inflammatory gel formulation containing a combination of diclofenac diethylamine (1.16%), linseed oil (3%), methyl salicylate (10%), and menthol (5%). Developed by Sunlife Pharmaceuticals, it is designed for the localized relief of pain and inflammation associated with musculoskeletal disorders, joint pain, osteoarthritis, sprains, strains, and bruises. Diclofenac diethylamine acts as a non-steroidal anti-inflammatory drug (NSAID) by inhibiting cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis. Methyl salicylate and menthol function as counterirritants, with menthol activating TRPM8 channels to produce a cooling sensation and dilate blood vessels, while methyl salicylate provides local anesthetic and anti-inflammatory effects. Linseed oil acts as an emollient and anti-inflammatory agent, helping to soothe the skin and enhance the penetration of the active ingredients.

Brand names
MobistarrMobistarr Gel
Other names
Diclofenac Diethylamine 1.16% + Linseed Oil 3% + Methyl Salicylate 10% + Menthol 5%diclofenac diethylamine + linseed oil + menthol + methyl salicylate
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)PTGS2 (Prostaglandin-Endoperoxide Synthase 2)TRPM8 (Transient receptor potential cation channel subfamily M member 8)

Beyond the preview

Go deeper on diclofenac diethylamine + linseed oil + menthol + methyl salicylate (Sun Pharma).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on diclofenac diethylamine + linseed oil + menthol + methyl salicylate (Sun Pharma).

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call